Compare ALB & UHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALB | UHS |
|---|---|---|
| Founded | 1994 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Hospital/Nursing Management |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9B | 14.4B |
| IPO Year | 1994 | N/A |
| Metric | ALB | UHS |
|---|---|---|
| Price | $126.51 | $230.90 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 20 | 12 |
| Target Price | $102.16 | ★ $232.58 |
| AVG Volume (30 Days) | ★ 4.2M | 663.8K |
| Earning Date | 11-05-2025 | 10-27-2025 |
| Dividend Yield | ★ 1.29% | 0.35% |
| EPS Growth | N/A | ★ 39.76 |
| EPS | N/A | ★ 21.01 |
| Revenue | $4,946,415,000.00 | ★ $16,992,503,000.00 |
| Revenue This Year | N/A | $10.93 |
| Revenue Next Year | $1.29 | $4.96 |
| P/E Ratio | ★ N/A | $11.00 |
| Revenue Growth | N/A | ★ 10.21 |
| 52 Week Low | $49.43 | $152.33 |
| 52 Week High | $132.90 | $246.33 |
| Indicator | ALB | UHS |
|---|---|---|
| Relative Strength Index (RSI) | 61.13 | 53.49 |
| Support Level | $117.61 | $228.00 |
| Resistance Level | $132.90 | $246.33 |
| Average True Range (ATR) | 6.16 | 5.99 |
| MACD | -0.42 | -1.35 |
| Stochastic Oscillator | 65.52 | 37.86 |
Albemarle is one of the world's largest lithium producers. In the lithium industry, the majority of demand comes from batteries, where lithium is used as the energy storage material, particularly in electric vehicles. Albemarle is a fully integrated lithium producer. Its upstream resources include salt brine deposits in Chile and the US and two hard rock mines in Australia, both of which are joint ventures. The company operates lithium refining plants in Chile, the US, Australia, and China. Albemarle is a global leader in the production of bromine, used in flame retardants.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.